NRC NRC Health: Business Value to Revenue

Public company logo of nrchealth.com (NRC)

A stable liquidity surplus and long-term contracts ensure high margins for National Research (NRC), which smooths out volatility on the chart. The Enterprise Value to revenue ratio is based on AI-driven review analysis and SaaS solutions, while unique data allows the company to flexibly manage its pricing power. The current value of the metric is 4378.61, reflecting the market consensus regarding the business's real valuation.

National Research Corp. (NRC): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/20/2026

National Research Corporation - analytical breakdowns and key metrics (NRC)

- current price and projected stock value:
- company stock capitalization data:
Initial company analysis:National Research Corp. NRC
Core merchandise of NRC Health

Investors are verifying the issuer's reliability through multiples that assess the efficiency of cash flow generation. This enterprise value-to-revenue ratio combines market capitalization and net debt, eliminating the impact of credit load on the business valuation. The stability of this chart confirms the maturity of National Research (NRC). A diversified medical client base minimizes revenue volatility, ensuring the predictability of the metric. The smooth trend signals a fundamental equilibrium in asset value.

Competitor analysis for National Research

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|OMCL - Company Value to Revenue|GDRX - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Schrodinger Corp SDGR|PHR: EV/Sales Multiple|OMDA - Total Company Value-to-Revenue Ratio|EVH (Evolent Health Inc) - EV/Sales Multiple|Company Value to Revenue Ratio HSTM (HealthStream)|EV/Sales Multiple DH|CCSI (Consensus Corp) - Business Value to Revenue|agilon health Inc - Company Value to Revenue|absci.com - Enterprise Value-to-Revenue Ratio|SY - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)